Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin aspart injection volume study in type 1 diabetes
2011-000780-27Phase 4Completed
- Sponsor
- Medical University of Graz
- Start
- Apr 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of insulin aspart in diabetes mellitus type 1 (T1D) (2 arms), sponsored by Medical University of Graz. Primary endpoint: Time to maximum observed serum insulin concentration. Started Apr 2011; status: completed.
02
Drugs
insulin aspart
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2011-000780-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000780-27.